Arkolith/Insider Trading/WST/Form 4

Winters Chad

VP, Chief Accounting OfficerWEST PHARMACEUTICAL SERVICES INC (WST) · full profile →Form 4 · filed Mar 3, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 1, 2026Grant(A)808—$0808
Mar 1, 2026Grant(A)340—$0340

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000105770-26-000033) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML